Jürgen Zschocke
Eli Lilly (Germany)(DE)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Genetics and Neurodevelopmental Disorders, Neuroscience and Neuropharmacology Research, Autophagy in Disease and Therapy, Signaling Pathways in Disease
Most-Cited Works
- → Association of FKBP51 with Priming of Autophagy Pathways and Mediation of Antidepressant Treatment Response: Evidence in Cells, Mice, and Humans(2014)175 cited
- → Differential Promotion of Glutamate Transporter Expression and Function by Glucocorticoids in Astrocytes from Various Brain Regions(2005)138 cited
- → Valproate and Amitriptyline Exert Common and Divergent Influences on Global and Gene Promoter-Specific Chromatin Modifications in Rat Primary Astrocytes(2009)135 cited
- → Antidepressant Drugs Diversely Affect Autophagy Pathways in Astrocytes and Neurons—Dissociation from Cholesterol Homeostasis(2011)107 cited
- → Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine(2015)105 cited
- → Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels(2012)82 cited
- → Brain Region-Specific Neuroprotective Action and Signaling of Corticotropin-Releasing Hormone in Primary Neurons(2003)80 cited
- → FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications(2015)65 cited
- → Estrogen Receptor α-mediated Silencing of Caveolin Gene Expression in Neuronal Cells(2002)62 cited
- → DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells(2007)58 cited